Clinical trials of a nasal coronavirus vaccine by Generium have begun in Moscow. This is reported TASS.
Earlier, Alexander Gintsburg disclosed the timing of the entry into civilian circulation of the nasal vaccine of the Gamaleya Center. According to him, this will happen in three to four months. Gunzburg stressed that the nasal vaccine will be effective against the omicron strain of coronavirus
#Clinical #trials #nasal #vaccine #COVID19 #Moscow